Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Verrica Pharmaceuticals Inc increased its cash reserves by 102.92%, or 35.27m. Cash Flow from Financing totalled 74.21m or 1,448.34% of revenues. In addition the company used 38.58m for operations while cash used for investing totalled 362.00k.
Cash flow per share | -1.86 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.3133 |
---|---|
Tangible book value per share | -0.3133 |
More ▼
Balance sheet in USDView more
Current ratio | 2.36 |
---|---|
Quick ratio | 2.23 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | 1.42 |
More ▼